This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
READ MORE: How Drug Benefit Design Trends Are Expected to Impact Pharmacists Don’t get left behind: Sign up today for our free Drug Topics newsletter and get the latest drug information, industry trends, and patientcare tips delivered straight to your inbox. Often those very high-end medicines are for very few people.
Last three blocks include Acute Care and two Electives Delivery: Onsite, hands-on experience combined with structured readings, discussions, and interprofessional meetings as available Elective Opportunities Students have 2 elective opportunities tailored to individual interests.
Our hospital pharmacy services our hospital and ED departments as well as outpatient infusion (including chemotherapy). Our hospital pharmacy also houses our long-term care pharmacy that fills prescriptions and manages medications for our skilled nursing residents.
Doshi, BSPH, PharmD Candidate Kari Franson, PharmD, PhD, BCPP Publication Article Drug Topics Journal Drug Topics July/August 2025 Volume 169 Issue 04 Rescheduling cannabis empowers pharmacists to lead in patientcare by evaluating safety, interactions, and formulations while providing education. tetrahydrocannabinol (THC).
Clinical Applications and Economic Impacts Biologics have significantly impacted cancer therapies by targeting cancer cells more specifically and reducing adverse events compared with traditional chemotherapy, Darkow noted. REFERENCE Darkow A. Decoding the Logic: An Overview of Biologics and Biosimilars.
A man aged 55 years with metastatic colorectal cancer was initiated on a standard fluoropyrimidine-based chemotherapy regimen. Within a week, he developed severe neutropenia, gastrointestinal shutdown, and septic complications requiring admission to the intensive care unit.
Kalis, PharmD, BCOP Key Takeaways Oncology pharmacy's complexity outpaces the generalist model, necessitating specialization for effective patientcare and operational efficiency. These are all important and necessary topics that help cancer centers run effectively and deliver exceptional patientcare.
Their goal was to promote consistent, high-quality, pharmacist-led care by standardizing the way clinical competence is evaluated—both at initial onboarding and as part of ongoing professional development. Using a roadmap strategy, the team established milestones and recruited expert pharmacists involved directly in CPA-driven patientcare.
1 "[Meloxicam injection] demonstrates our commitment to improving patientcare by providing an alternate dosage form for pain management," Ron Scarboro, chief executive officer at Azurity Pharmaceuticals, said in a press release.
Eugene Przespolewski, PharmD, BCOP, DPLA : At OPC, I presented a few different topics, really focused on care models and optimization. We talked about the pharmacist’s impact on patientcare, addressed challenges and concerns with AI, and also touched on drug shortages.
TRE-515 aims to extend patient lives and elevate current standards of care by combining radioligand therapy with novel drug approaches. SHOW MORE FDA fast-tracks TRE-515 for advanced prostate cancer, combining it with radiation therapy to enhance treatment outcomes and patientcare.
. + Rotation / Learning Experience Sterling Pharmacy (Retail APPE: 5 weeks) Description : Students will have opportunities to participate in patient centered dispensing roles as well as patientcare activities as part of mandatory rotation activities.
Beyond IBD, GLP-1 agonists may benefit conditions like short bowel syndrome (SBS) and chemotherapy-induced mucositis by slowing gastric emptying and improving intestinal absorption. They have the expertise to explain key detailslike proper injection techniques, side effects, and new indicationsto patients and fellow healthcare providers.
1 Biomarker testing is relatively new in the treatment landscape for NSCLC but has proven incredibly important for personalizing patientcare, transforming from a generic chemotherapy approach to a highly personalized, genomically driven treatment strategy. For advanced disease, chemotherapy was the standard.
Drug shortages are a common issue in the health care industry. Florida Cancer Specialists & Research Institute (FCS) is highly skilled at proactively managing the drug supplies it needs to care for patients.
“I do not believe this particular change will have any bearing on patientcare,” said Saad Usmani, a myeloma physician and cell therapist at Memorial Sloan Kettering who has also studied Carvykti.
In this heterogeneous patient group, decisions on therapies and management must follow a multidimensional approach, integrating medical, socio-economic and psychological factors. Drug classes known to cause falls are commonly used in older patients , but cancer treatment can further increase this risk.
Infusion pharmacy, also known as home care or specialty pharmacy, encompasses a variety of crucial medical services. From chemotherapy to nutrition support and infectious disease treatments, infusion pharmacists play a vital role in delivering specialized care directly to patients.
“The FDA approval of Epkinly represents a new treatment mechanism of action for third-line DLBCL patients. “As As a non-chemotherapy, single-agent treatment for DLBCL patients, we hope that Epkinly can effectively treat this aggressive cancer type and can be used for patientcare quickly and in an off-the-shelf form for physicians.
With an introduction from Helena Beer, Dr Kunene shares first-hand insights into the clinical trial, the NHS Cancer Vaccine Launch Pad initiative and their potential for revolutionising patientcare. Another treatment combination is chemotherapy with zolbetuximab – an antibody directed against claudin 18.6.
The CAR T-cell therapy tisagenlecleucel has recently been given the green light for routine rollout on the NHS to treat paediatric patients with acute lymphoblastic leukaemia. These patients often reach the ceiling for toxicity in terms of chemotherapy and radiotherapy in the context of a bone marrow transplant.
These proactive systems can enhance patientcare and have the potential to alleviate the burden on healthcare professionals by automating routine monitoring and treatment adjustments. This makes it a significant advancement beyond classical reactive AI.
Common drug classes that have been in short supply include: Antibiotics Electrolytes Hormone agents Chemotherapy Central nervous system drugs GLP-1 agonists What causes a medication shortage? Bottom line There are many ways pharmacists can support patients during a medication shortage. Many factors cause medication shortages.
In recent years, the NHS has been trialling the use of drones for a variety of purposes, including delivering medical supplies of blood packs and chemotherapy, transporting lab specimens, and more. Ms Walsh believes many other areas of the NHS could benefit from drones, including emergency care.
Chemotherapy agents: Chemotherapy agents can lead to constipation in a variety of ways such as slowing the movements of the intestinal tract or creating inflammation that disrupts digestive function. Take this month to recognize their expertise and the valuable support they provide in patientcare! 2020;12(1):205.
Furthermore, the duration of response with the PD-1 checkpoint inhibitor was nearly five times longer at 29 months versus just over six months with frontline chemotherapy. Another contender meanwhile also reported new data at ESMO.
Durvalumab is ‘promising step forward’ The latest approval from the MHRA is based on positive data from the AEGEAN Phase III trial in rNSCLC , which showed that durvalumab-based treatment before and after surgery reduced the risk of recurrence, progression events or death by 32% versus neoadjuvant chemotherapy alone.
Beyond significant cost savings, biosimilar uptake has been shown to simultaneously improve patient access, varying by country. A subsequent change in guidance moved this biologic to a first-line treatment, resulting in an increase in the number of patients who could receive this much-needed treatment by 104%.
Chemotherapy-induced nausea and vomiting (CINV) can be acute, delayed or anticipatory. The emetogenic potential of chemotherapy needs to be taken into account when selecting treatment. The America Society for Clinical Oncology (ASCO) has clear guidelines for evidence-based management of dyspnoea, he said.
But consider the following: Hiring Inadequate Staff. When my wife was a patient in the hospital, there were 24 patients on her floor. During the day shift, there were 4 registered nurses (RNs) and 3 patientcare technicians (PCTs). But who decided that 1 RN for every 6, 8, or 12 patients was proper staffing?
In the continuous evolving landscape of healthcare, wearable injectors have emerged as transformative devices with the potential to redefine patientcare. These innovative instruments combine precision, convenience, and patient-centered design to revolutionize drug delivery.
A unique health data ecosystem for improving patientcare. The strength of the data is such that it can also be used for the early identification of adverse events, to highlight which patients are suitable to participate in studies and to provide real-world evidence about an intervention’s impact on patientcare and outcomes.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content